EBS News and Press, Emergent Biosolutions Inc. From 07/21/20

GAITHERSBURG, Md., July 21, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Standard & Poor’s (S&P) has indicated that the company will be added to the S&P MidCap 400 ® index, effective prior to the open of trading on Friday, Jul...

NEW YORK , July 20, 2020 /PRNewswire/ -- S&P SmallCap 600 constituent Emergent BioSolutions Inc. (NYSE: EBS) will replace Caesars Entertainment Corp. (NASD: CZR) in the S&P MidCap 400, and First Hawaiian Inc. (NASD:FHB) will replace Emergent BioSolutions in the S&P SmallC...

First Hawaiian (NASDAQ: FHB ) is up 5.3% postmarket after news that it's moving into the S&P SmallCap 600 index . More news on: First Hawaiian, Inc., Emergent BioSolutions Inc., Caesars Entertainment Corporation, Financial stocks news, Stocks on the move, Healthcare stocks news ...

GAITHERSBURG, Md., July 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the financial results for the second quarter of 2020, recent business developments, revenue guidance for th...

Johnson & Johnson (NYSE: JNJ) has been a leader in the pharmaceutical industry for over 130 years. With a vast product portfolio and a 2.8% dividend yield, the stock remains popular with income investors despite a history of modest year-over-year gains. The company experienced 6.7% sales...

Vaxart (NASDAQ: VXRT) , a biotech company focused on the development of oral vaccines, had an underwhelming performance in the stock market in 2019 with its shares dropping by more than 80%. But largely thanks to the company's efforts to develop a vaccine for COVID-19, the stock has soared by...

Biotech Stocks Are On The Rise Amid News From Novavax When we hear the term coronavirus stocks , it can refer to a broad range of sectors. Depending on the context, it could be the new-economy stocks, spanning from gaming companies and online food delivery to biotech stocks . Like it or not,...

Emergent BioSolutions ( EBS +5.4% ) is partnering with Mount Sinai to test its experimental COVID-19 hyperimmune globulin treatment, COVID-HIG, derived from the blood plasma of recovered Covid-19 patients. More news on: Emergent BioSolutions Inc., Healthcare stocks news, Read ...

Mount Sinai and Emergent to conduct clinical trials to evaluate COVID-HIG for post-exposure prophylaxis of COVID-19 in front-line health care workers and to support a potential Expanded Access Program for military personnel with funding from the U.S. Department of Defense ImmunoTek to ext...

( Pexels ) Of all the investable sectors and industries, one of the top-performing over the past few months is biotechnology. Since its March low (18 th ), the SPDR Biotech ETF ( XBI ) has risen about 75% as investors speculate on virus treatment and vaccine rumors. Understandably, many in...